Net Income

Bolstered by a major investment and a key nuclear fusion deal, Next Hydrogen's new strategy and leadership signal a shift from R&D to commercial reality.

The optics giant posted record revenue and soaring profits, yet its stock is near a 52-week low. The market sees a smartphone slump; Sunny sees a future in AI.

Global ingredient giant Ingredion partners with CIBO Technologies, using AI and satellite data to scale regenerative agriculture and meet ambitious ESG goals.

The conglomerate's massive impairment signals a strategic pivot to shed legacy assets and double down on its high-growth core businesses in pharma and tourism.

Aflac Re Bermuda's first external reinsurance transaction with Japan Post Insurance signals a major strategic shift in Japan's competitive insurance market.

Tech advisor Crosslake lands a major new investment from Falfurrias and Leonard Green, signaling a strategic shift in private equity exit strategies.

The neurotech pioneer reports strong sales for its spinal cord injury therapy, secures key FDA approvals, and plans for major US stock market entry.

A new, highly selective oral drug for the most common form of dwarfism has been cleared for U.S. trials, offering hope for a more convenient treatment.

A shocking new installation reveals a dangerous blind spot: your car isn't protecting you from the sun's harmful rays. Here's what you need to know.

The digital lender's record revenue and new blockchain platform aim to unlock trillions in illiquid home equity, charting a bold path to profitability.

After a successful shift to a royalty model, the firm reports stronger financials and confirms it is weighing a merger or acquisition.

The robotics firm completed crucial benchtop tests for its novel single-port system, a major step toward clinical use and challenging market leaders.

Sangamo pushes a promising Fabry disease therapy toward the FDA while a cash crunch forces a strategic pivot to brain-targeting neurological cures.

NASDAQ-listed Bio Green Med Solution abandons its biopharma roots for fire safety, slashing losses but facing new questions about its long-term survival.

As The Hanover prepares its Q1 2026 report, investors watch to see if it can sustain momentum amid inflation, high rates, and catastrophe risks.

Luxury brand Perfect Moment lands a $12M financing package, including an equity deal at a 75% premium, signaling a major vote of confidence for its China expansion.

In a strategic move to dominate the future of warfare, Red Cat Holdings has acquired Apium Swarm Robotics, deepening its role in a new defense tech race.

With new leadership and better finances, Star Diamond pushes its massive diamond project forward, but funding challenges and a volatile market loom large.

Jeffrey Hollender's new book reveals the untold story of building a green empire, the pain of being fired, and the fight to keep a mission alive.

Asia's top logistics firm posts record RMB 11.1B profit, outpacing rivals and rewarding investors with a massive dividend and share buyback plan.